Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.660
-0.050 (-2.92%)
At close: Sep 26, 2025, 4:00 PM EDT
1.690
+0.030 (1.80%)
After-hours: Sep 26, 2025, 7:50 PM EDT
Bionano Genomics Revenue
Bionano Genomics had revenue of $6.73M in the quarter ending June 30, 2025, a decrease of -13.36%. This brings the company's revenue in the last twelve months to $27.43M, down -25.02% year-over-year. In the year 2024, Bionano Genomics had annual revenue of $30.78M, down -14.79%.
Revenue (ttm)
$27.43M
Revenue Growth
-25.02%
P/S Ratio
0.14
Revenue / Employee
$274,260
Employees
100
Market Cap
16.07M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BNGO News
- 9 days ago - Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge - Benzinga
- 10 days ago - Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering - GlobeNewsWire
- 11 days ago - Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge - Benzinga
- 11 days ago - Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology - GlobeNewsWire
- 12 days ago - CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders - GlobeNewsWire
- 4 weeks ago - Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress - GlobeNewsWire